These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38818625)

  • 21. Advancements in the studies of novel nanomaterials for inner ear drug delivery.
    Zhang L; Bai X; Wang R; Xu L; Ma J; Xu Y; Lu Z
    Nanomedicine (Lond); 2022 Aug; 17(20):1463-1475. PubMed ID: 36189895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anatomical basis of drug delivery to the inner ear.
    Glueckert R; Johnson Chacko L; Rask-Andersen H; Liu W; Handschuh S; Schrott-Fischer A
    Hear Res; 2018 Oct; 368():10-27. PubMed ID: 30442227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a drug delivery system for the inner ear using poly(amino acid)-based nanoparticles.
    Kim DK; Park SN; Park KH; Park CW; Yang KJ; Kim JD; Kim MS
    Drug Deliv; 2015 May; 22(3):367-74. PubMed ID: 24447111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovector-mediated gene delivery to human umbilical cord mesenchymal stromal cells induces inner ear cell phenotype.
    Devarajan K; Forrest ML; Detamore MS; Staecker H
    Cell Reprogram; 2013 Feb; 15(1):43-54. PubMed ID: 23379581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Application of Mesenchymal Stem Cells for Cochlear Regeneration.
    Maharajan N; Cho GW; Jang CH
    In Vivo; 2021; 35(1):13-22. PubMed ID: 33402445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs and epigenetic regulation in the mammalian inner ear: implications for deafness.
    Friedman LM; Avraham KB
    Mamm Genome; 2009; 20(9-10):581-603. PubMed ID: 19876605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probucol-bile acid based nanoparticles protect auditory cells from oxidative stress: an
    Wagle SR; Kovacevic B; Ionescu CM; Foster T; Jones M; Mikov M; Wise A; Mooranian A; Al-Salami H
    Ther Deliv; 2024 Apr; 15(4):237-252. PubMed ID: 38469721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational analysis of mRNA expression profiling in the inner ear reveals candidate transcription factors associated with proliferation, differentiation, and deafness.
    Perl K; Shamir R; Avraham KB
    Hum Genomics; 2018 Jun; 12(1):30. PubMed ID: 29929553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Genomics of Auditory Function and Disease.
    Taiber S; Gwilliam K; Hertzano R; Avraham KB
    Annu Rev Genomics Hum Genet; 2022 Aug; 23():275-299. PubMed ID: 35667089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status and prospects of gene therapy for the inner ear.
    Sun H; Huang A; Cao S
    Hum Gene Ther; 2011 Nov; 22(11):1311-22. PubMed ID: 21338273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse.
    Isgrig K; Chien WW
    J Vis Exp; 2018 Mar; (133):. PubMed ID: 29553564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keynote review: The auditory system, hearing loss and potential targets for drug development.
    Holley MC
    Drug Discov Today; 2005 Oct; 10(19):1269-82. PubMed ID: 16214671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs in inner ear biology and pathogenesis.
    Patel M; Hu BH
    Hear Res; 2012 May; 287(1-2):6-14. PubMed ID: 22484222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Approaches for Ear-targeted Delivery Systems in Neurosensory Disorders to avoid Chronic Hearing Loss Mediated Neurological Diseases.
    Verma R; Vyas P; Kaur J; Javed MN; Sarafroz M; Ahmad M; Gilani SJ; Taleuzzaman M
    CNS Neurol Disord Drug Targets; 2022; 21(6):479-491. PubMed ID: 34477535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials for inner ear drugs: Design and execution challenges.
    Jung DH; Rauch SD
    Hear Res; 2018 Oct; 368():123-126. PubMed ID: 29602591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of Mesenchymal Stem Cell Therapy and Inner Ear Regeneration for Hearing Loss: A Review.
    Kanzaki S; Toyoda M; Umezawa A; Ogawa K
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhesus Cochlear and Vestibular Functions Are Preserved After Inner Ear Injection of Saline Volume Sufficient for Gene Therapy Delivery.
    Dai C; Lehar M; Sun DQ; Rvt LS; Carey JP; MacLachlan T; Brough D; Staecker H; Della Santina AM; Hullar TE; Della Santina CC
    J Assoc Res Otolaryngol; 2017 Aug; 18(4):601-617. PubMed ID: 28646272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotrophic receptors as potential therapy targets in postnatal development, in adult, and in hearing loss-affected inner ear.
    Bitsche M; Dudas J; Roy S; Potrusil T; Schmutzhard J; Schrott-Fischer A
    Otol Neurotol; 2011 Jul; 32(5):761-73. PubMed ID: 21646930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prestin-targeting peptide-guided drug delivery system rearranging concentration gradient in the inner ear: An improved strategy against hearing loss.
    Wang X; Zhou Z; Yu C; He K; Sun L; Kou Y; Zhang M; Zhang Z; Luo P; Wen L; Chen G
    Eur J Pharm Sci; 2023 Aug; 187():106490. PubMed ID: 37295658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local drug delivery to the inner ear: Principles, practice, and future challenges.
    Plontke SK; Salt AN
    Hear Res; 2018 Oct; 368():1-2. PubMed ID: 30006112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.